-
Induction of a Systemic Immune Response during Use of an Allogenic Leukemia-Derived Dendritic Cell Vaccine in MRD+ AML Patients Correlates with Clinical Response and MRD Conversion
Arjan A. van de Loosdrecht, Jacqueline J Cloos, Eva‐Maria Wagner‐Drouet, Uwe Platzbecker, Tobias A.W. Holderried, Catharina H. M. J. van Elssen, +6 more
1citations -
Tandem Substitutions in Somatic Hypermutation2021 Blood conference-abstract Biochemistry, Genetics and Molecular Biology DNA Repair Mechanisms Open access
Marvyn T. Koning, Julieta Sepúlveda-Yáñez, Diego Álvarez-Saravia, Bas Pilzecker, Pauline A. van Schouwenburg, Mirjam van der Burg, +3 more
1citations -
Indirect Treatment Comparisons of Daratumumab, Pomalidomide, and Dexamethasone Versus Daratumumab, Bortezomib, and Dexamethasone or Bortezomib and Dexamethasone in Patients with Difficult-to-Treat Relapsed/Refractory Multiple Myeloma
Jianming He, Heather Berringer, Bart M. S. Heeg, Tobias Kampfenkel, João Mendes, Annette Lam, +1 more
1citations -
Sustained Improvement in Health-Related Quality of Life in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone: Update of the Phase 3 MAIA Trial
Aurore Perrot, Thierry T.F. Facon, Shaji Kunnathu Kumar, Torben Plesner, Robert Zygmunt Orlowski, Philippe Moreau, +24 more
1citations -
Post-Transplant Cyclophosphamide (PTCY) Compared to ATG in Patients with Myelodysplastic Neoplasms Allografted with an Unrelated Donor: A Registry Study of the Chronic Malignancies Working Party of the EBMT
Yves Chalandon, Dirk‐Jan Eikema, Ivan Moiseev, Fabio Ciceri, Linda Köster, Jan Vydra, +16 more
1citations -
Rationale for and Design of Papilio-1: A Phase 1/2, Multicenter, Open-Label Study to Evaluate the Feasibility, Safety, and Efficacy of Point-of-Care-Manufactured Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells (GLPG5301) in Relapsed/Refractory Multiple Myeloma
Niels W.C.J. van de Donk, Sébastien Anguille, Jo Caers, Marte C. Liefaard, Christian J. Jacques, Anna D.D. van Muyden
1citations -
Phase 2 Study of Daratumumab (DARA) Plus Bortezomib, Cyclophosphamide, and Dexamethasone (D-VCd) in a Diverse Patient Population with Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis: Aquarius2023 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Michael Alan Rosenzweig, Yvonne Adeduni Efebera, Efstathios Kastritis, Brandon Jamaal Blue, Faizi A. Jamal, Monique C. Minnema, +10 more
1citations -
Mismatched Unrelated Donor Transplantation with Ptcy-Based Gvhd Prophylaxis Is Associated with Better Survival Than Double Unit Umbilical Cord Blood Transplantation in Patients with AML in First CR: A Study from the ALWP of the EBMT
Frédéric Baron, Myriam Labopin, Jurjen Versluis, Jan Vydra, Peter A. von dem Borne, Emma Nicholson, +12 more
1citations -
Single-Cell-Multiomics Demonstrates Molecular Efficacy of a Clinical Lentiviral Vector for Gene Therapy of RPS19-Deficient Diamond-Blackfan Anemia2023 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Virus-based gene therapy research
Sofia Freiman, Jun Chen, Johan Flygare, Chayenne Kampman, Karin Pike‐Overzet, Alexander B. Mohseny, +6 more
1citations -
Encouraging Outcome of AML with t(8;16) Following Allogeneic Stem Cell Transplantation in First Remission - a Retrospective Analysis on Behalf of the Acute Leukemia Working Party of the EBMT
Ann‐Kristin Schmälter, Myriam Labopin, Jurjen Versluis, Maria Pilar Gallego Hernanz, Matthias Eder, Peter A. von dem Borne, +12 more
1citations -
Prediction of Poor Survival after Hematopoietic Cell Transplantation in Myelofibrosis Using Machine Learning Techniques2024 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Juan Carlos Hernández‐Boluda, Adrián Mosquera Orgueira, Luuk A. Gras, Linda Köster, Joe Tuffnell, Nicolaus Martin Kröger, +24 more
1citations -
Outcome of Patients with HTLV-1 Adult T-Cell Leukemia/Lymphoma (ATL) after Allogeneic SCT: Results of the EBMT LWP2024 Blood conference-abstract Immunology and Microbiology T-cell and Retrovirus Studies Open access
Ali A. Bazarbachi, Ambroise Marçais, Maud Ngoya, Irma Khvedelidze, Ben Carpenter, Victoria T. Potter, +11 more
1citations -
Health-Related Quality of Life in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma: Data from the Perseus Trial of Subcutaneous Daratumumab Combined with Bortezomib, Lenalidomide, and Dexamethasone (D-VRd)
Pieter Sonneveld, Meletios Athanasios Dimopoulos, Mario Boccadoro, Hang Quach, Phoebe Joy Ho, Meral Beksaç, +38 more
1citations